RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Clayton Yates to Mitogen-Activated Protein Kinase Kinases

Back to Details
This is a "connection" page, showing publications Clayton Yates has written about Mitogen-Activated Protein Kinase Kinases.
Clayton Yates
Connection Strength
0.199
Mitogen-Activated Protein Kinase Kinases
  1. Wang Y, Liu S, Yang Z, Algazi AP, Lomeli SH, Wang Y, Othus M, Hong A, Wang X, Randolph CE, Jones AM, Bosenberg MW, Byrum SD, Tackett AJ, Lopez H, Yates C, Solit DB, Ribas A, Piva M, Moriceau G, Lo RS. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy. Cancer Cell. 2021 10 11; 39(10):1375-1387.e6.
    View in: PubMed
    Score: 0.199
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support